STING1 and stroke disorder: Researchers employed the STING-specific antagonist SN-011 in mice with ischemic stroke induced by middle cerebral artery occlusion, resulting in reduced early inflammation and improved stroke pathology through altered phagocyte activity that supports myelin regeneration (66).